Role of tipranavir in treatment of patients with multidrug-resistant HIV

The worldwide emergence of multidrug-resistant human immunodeficiency virus (HIV)-1 strains has the driven the development of new antiretroviral (ARV) agents. Over the past 5 years, HIV-entry and integrase inhibitor ARVs, as well as improved non-nucleoside reverse transcriptase inhibitors (NRTIs) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Courter, Joshua D, Teevan, Colleen J, Li, Michael H, Girotto, Jennifer E, Salazar, Juan C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952481/
https://www.ncbi.nlm.nih.gov/pubmed/20957134
http://dx.doi.org/10.2147/TCRM.S4207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952481/
https://www.ncbi.nlm.nih.gov/pubmed/20957134
http://dx.doi.org/10.2147/TCRM.S4207

Ejemplares similares